Table 2.

Results of the mendelian randomization analysis.

Exposures	Outcome	Method	MR			p	Heterogeneity		Pleiotropy		p
			beta	SE	OR (95%CI)		Q	p	Intercept	SE
Basophil count	CAD	MR egger	−0.063	0.110	0.94 (0.72–1.16)	0.576	43.815	0.002	−0.001	0.006	0.856
		Weighted median	−0.052	0.043	0.95 (0.86–1.03)	0.230
		IVW	−0.081	0.041	0.92 (0.84–1.00)	0.048	43.890	0.002
Eosinophil petcentage	CAD	IVW	−0.022	0.149	0.98 (0.69–1.27)	0.881	488.451	<0.05
Monocyte count	CAD	MR egger	0.005	0.034	1.00 (0.94–1.07)	0.888	9.943	0.446	−0.004	0.005	0.433
		Weighted median	−0.006	0.017	0.99 (0.96–1.03)	0.725
		IVW	−0.021	0.012	0.98 (0.96–1.00)	0.072	10.610	0.477
Neutrophil count	CAD	MR egger	0.058	0.096	1.06 (0.87–1.25)	0.546	67.531	<0.05	−0.001	0.006	0.846
		Weighted median	0.053	0.036	1.05 (0.99–1.12)	0.133
		IVW	0.041	0.033	1.04 (0.98–1.11)	0.216	67.617	<0.05
C-reactive protein	CAD	MR egger	−0.407	0.141	0.67 (0.39–0.94)	0.008	178.849	<0.05	0.025	0.012	0.053
		Weighted median	−0.096	0.051	0.91 (0.81–1.01)	0.058
		IVW	−0.141	0.069	0.87 (0.73–1.00)	0.040	212.759	<0.05
Lymphocyte count	CAD	MR egger	0.007	0.071	1.01 (0.87–1.15)	0.924	1,074.044	<0.05	0.003	0.002	0.168
		Weighted median	0.031	0.029	1.03 (0.98–1.09)	0.285
		IVW	0.095	0.030	1.10 (1.04–1.16)	0.001	1,081.179	<0.05

CAD, coronary artery disease; SE standard error.